Your browser doesn't support javascript.
loading
Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitor.
Silver, P J; Dundore, R L; Bode, D C; de Garavilla, L; Buchholz, R A; van Aller, G; Hamel, L T; Bacon, E; Singh, B; Lesher, G Y.
Affiliation
  • Silver PJ; Department of Pharmacology, Sterling Winthrop Pharmaceuticals Research Division, Collegeville, Pennsylvania.
J Pharmacol Exp Ther ; 271(3): 1143-9, 1994 Dec.
Article in En | MEDLINE | ID: mdl-7996419
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Phosphodiesterase Inhibitors / Pyrimidines / 3',5'-Cyclic-GMP Phosphodiesterases Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Pharmacol Exp Ther Year: 1994 Document type: Article Country of publication: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Phosphodiesterase Inhibitors / Pyrimidines / 3',5'-Cyclic-GMP Phosphodiesterases Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Pharmacol Exp Ther Year: 1994 Document type: Article Country of publication: United States